Literature DB >> 6461269

Purpura fulminans.

D Z Chu, F W Blaisdell.   

Abstract

Purpura fulminans presents as a catastrophic illness with gangrene of the distal extremities and necrosis of skin. The clinical picture consists of septicemia, shock, and disseminated intravascular coagulation. The Shwartzman and Arthus reactions are thought to be responsible for the pathogenesis of purpura fulminans. The exact mechanisms of these reactions are not completely understood. Immediate resuscitation is the treatment for shock and sepsis. Heparin is recommended to reverse the disseminated intravascular coagulation component of this disease. Surviving patients require treatment of skin necrosis and digital and extremity gangrene. The former are managed in a fashion similar to the management of burns. Amputation should be delayed until maximal collateral circulation has developed. A series of 10 patients is presented and 58 cases from the literature are analyzed.

Entities:  

Mesh:

Year:  1982        PMID: 6461269     DOI: 10.1016/0002-9610(82)90106-4

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  4 in total

1.  A rare association of rhabdomyolysis and purpura fulminans in Strep. pneumoniae septicemia.

Authors:  E L Marcus; M Hersch; M Sonnenblick
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  Spot diagnosis: An ominous rash in a newborn.

Authors:  Kam-Lun Hon; King-Woon So; William Wong; Kam-Lau Cheung
Journal:  Ital J Pediatr       Date:  2009-04-30       Impact factor: 2.638

Review 3.  Surgical outcomes in adults with purpura fulminans: a systematic review and patient-level meta-synthesis.

Authors:  Kevin M Klifto; Caresse F Gurno; Michael J Grzelak; Stella M Seal; Mohammed Asif; C Scott Hultman; Julie A Caffrey
Journal:  Burns Trauma       Date:  2019-10-18

4.  Four limb amputations due to peripheral gangrene from inotrope use - Case report and review of the literature.

Authors:  Chuan Han Ang; Oon Thien Koo; Tet Sen Howe
Journal:  Int J Surg Case Rep       Date:  2015-07-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.